Grassley Statement on Two Charity-related Amendments Filed to Health Care Reform Bill

Mr. Chairman, while we are on the topic of compensation, I wanted to take theopportunity to discuss my amendments regarding executive compensation andgovernance of nonprofit organizations. They are Grassley amendments F7 and F8. I willnot ask for a vote on these at this time. These should be nonpartisan, good governanceproposals so if any of my […]

Grassley Welcomes New Transparency in Miscellaneous Tariff Bill Process

WASHINGTON – Sen. Chuck Grassley, ranking member of the Finance Committee, today joined the committee chairman, Sen. Max Baucus, in announcing the initiation of a process to develop a miscellaneous tariff bill in the 111th Congress. Grassley has long sought greater transparency regarding lobbying activities associated with miscellaneous tariff bills before he would support a […]

Grassley: IRS Whistleblower Program Could Catch Tax Fraud if Agency Focuses

Sen. Chuck Grassley, ranking member of the Committee on Finance, has worked to improve the whistleblower program at the Internal Revenue Service (IRS) to fight tax fraud. Grassley is the Senate author of the 1986 whistleblower amendments to the federal False Claims Act. He made the following comment on the IRS’ annual report on its […]

Finance Committee Tax Staff Review of ACORN Tax-exempt Status

TO: Senator GrassleyFROM: Tax StaffRE: Review of ACORN Tax-exempt StatusDATE: September 22, 2009 ACORN and IRS Responses ACORN, through its attorney, provided three responses to your letter of October25, 2006. ACORN’s response was essentially that it was not a tax-exemptentity. After receiving ACORN’s first response dated November 3, 2006, you wrote tothe Internal Revenue Service […]

Grassley comment on FDA announcement about review of ReGen’s Menaflex device

M E M O R A N D U M TO: Reporters and EditorsFR: Jill Kozeny, 202-224-1308 for U.S. Senator Chuck Grassley, Ranking Member of the Committee on FinanceRE: FDA announcement re. ReGen’s Menaflex device Senator Chuck Grassley issued the comment below about the announcement made todayby the Food and Drug Administration about the agency’s […]

Grassley applauds FDA commissioning of IOM study of system reviewing medical device safety

WASHINGTON — Senator Chuck Grassley said it was good news that the Food and Drug Administration has commissioned the Institute of Medicine to examine the agency’s 510(k) system for clearing medical devices. The 501(k) system is used for reviewing most devices approved by the agency. It is less stringent than FDA’s premarket approval process used […]